Facebook Linkedin Youtube X-twitter Instagram
Professional Syndicates Complex, Sharif Abdel Hamid Sharaf Street, 31, Amman, Jordan
About Jordan
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
Login
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
  • من نحن
    • تاريخ الجمعية
    • هيكل الجمعية
    • ادارة الجمعية
    • تطوع معنا
  • العضوية
    • طلب انتساب
    • الاعضاء المنتسبون
    • Types of memberships in the Society of Cardiologists
  • Home
  • نشاطات
  • مواد علمية
  • Health Education
  • جاليري
    • فيديو
    • صور
  • اتصل بنا
Uncategorized
webadmin April 13, 2025 0

Why researchers believe silver nanoparticles could ‘revolutionize’ medical imaging.

Why researchers believe silver nanoparticles could ‘revolutionize’ medical imaging.

1. Study Date and Source:
• Published on April 9, 2025
• Source: Health Imaging
• Author: Hannah Murphy
2. Institution:
• Research conducted at Oregon State University (OSU)
3. Research Focus:
• Development of uniform silver nanoparticles to improve the targeting ability of CT contrast agents, especially for cancer imaging.
4. Lead Researcher:
• Marilyn Mackiewicz, PhD, associate professor of chemistry at OSU.
5. Medical Application:
• Goal is to use silver nanoparticles to track and highlight cancer cells during X-ray CT imaging by designing agents that selectively accumulate in cancerous tissue.
6. Scientific Challenge:
• Current silver nanoparticles vary in size and shape, making them unstable and unreliable for consistent medical use.
7. Innovative Solution:
• Using ultraviolet (UV) light, oxygen, and silver ions to convert particles into uniform triangle shapes.
• Coating them with a hybrid lipid membrane increases stability and biocompatibility.
8. Advantages:
• Uniform shape and size improve effectiveness, reliability, and safety.
• Potential to replace existing CT contrast agents with a more targeted, low-toxicity alternative.
9. Future Vision:
• These advancements could enable in vivo imaging with reduced toxicity risks.
• Researchers hope the findings will enhance nanoparticle synthesis for broader use in medical imaging and beyond. 1. Study Date and Source:
• Published on April 9, 2025
• Source: Health Imaging
• Author: Hannah Murphy
2. Institution:
• Research conducted at Oregon State University (OSU)
3. Research Focus:
• Development of uniform silver nanoparticles to improve the targeting ability of CT contrast agents, especially for cancer imaging.
4. Lead Researcher:
• Marilyn Mackiewicz, PhD, associate professor of chemistry at OSU.
5. Medical Application:
• Goal is to use silver nanoparticles to track and highlight cancer cells during X-ray CT imaging by designing agents that selectively accumulate in cancerous tissue.
6. Scientific Challenge:
• Current silver nanoparticles vary in size and shape, making them unstable and unreliable for consistent medical use.
7. Innovative Solution:
• Using ultraviolet (UV) light, oxygen, and silver ions to convert particles into uniform triangle shapes.
• Coating them with a hybrid lipid membrane increases stability and biocompatibility.
8. Advantages:
• Uniform shape and size improve effectiveness, reliability, and safety.
• Potential to replace existing CT contrast agents with a more targeted, low-toxicity alternative.
9. Future Vision:
• These advancements could enable in vivo imaging with reduced toxicity risks.
• Researchers hope the findings will enhance nanoparticle synthesis for broader use in medical imaging and beyond.
🔗 https://healthimaging.com/topics/medical-imaging/imaging-contrast/why-researchers-believe-silver-nanoparticles-could-revolutionize-medical-imaging

439 Views
36
Right heart cardiac ultrasound contrast agent for shunts enters U.S. trial ASI-O2. Highlighted by MDPI. April 09, 2025April 13, 2025
Why Some Patients Are More Susceptible to side effects in patients who have been given gadolinium during MRI exams. April 13, 2025

مقالات ذات صلة

Uncategorized

IHD , without RIsk Factors( SMuRF-Less )but Inflamed: Is Inflammation the Missing Link in Women’s Heart Disease?

jordan heart January 12, 2026
Uncategorized

Draft – Jordanian AF Management Framework 2025 (Adapted from ESC and AHA Guidelines using the PIPOH Model)

jordan heart October 27, 2025

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

احدث المقالات

  • 2026 – U.S. Cardiovascular Health Report “The Good, the Bad, and the Ugly” — JACC
  • 2026 ACC/AHA Multisociety PAD Guidelines – Pharmacologic Therapy
  • CAD, without RIsk Factors(=SMuRF-Less )but Inflamed: Is Inflammation the Missing Link in Women’s Heart Disease?
  • IHD , without RIsk Factors( SMuRF-Less )but Inflamed: Is Inflammation the Missing Link in Women’s Heart Disease?
  • A Paradigm Shift in Nutrition: Real Food Over Fear of Fat

فئات

  • Health Education
  • Previous lectures and conferences
  • Uncategorized

Jordanian Cardiology Society

Jordanian Cardiology Society

Amman-Jordan

00962795001983

Working hours

From Sunday to Thursday

From nine in the morning until four in the afternoon

Important Links

Jordanian Cardiology Society

Research and studies

Medical articles

Login

Privacy Policy

Refund Policy

Cancellation Policy

Delivery Policy

Association Location

Copyright © 2024 Jordanian Cardiologists Association by WebAppRoots. All Rights Reserved.